These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8935814)

  • 1. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
    Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
    Ahmed S; Chengappa KN; Naidu VR; Baker RW; Parepally H; Schooler NR
    J Clin Psychiatry; 1998 Sep; 59(9):472-7. PubMed ID: 9771818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine.
    Poyurovsky M; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 1996 Dec; 11(4):283-6. PubMed ID: 9031996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin syndrome associated with clozapine withdrawal.
    Stevenson E; Schembri F; Green DM; Burns JD
    JAMA Neurol; 2013 Aug; 70(8):1054-5. PubMed ID: 23753931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients.
    Spivak B; Mester R; Wittenberg N; Maman Z; Weizman A
    Clin Neuropharmacol; 1997 Oct; 20(5):442-6. PubMed ID: 9331521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.
    Seppälä N; Kovio C; Leinonen E
    CNS Drugs; 2005; 19(12):1049-55. PubMed ID: 16332145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review.
    Yee B; Looi JCL; Agaciak M; Allison S; Chan SKW; Bastiampillai T
    East Asian Arch Psychiatry; 2023 Jun; 33(2):44-64. PubMed ID: 37400227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
    Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
    Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.
    Poyurovsky M; Bergman Y; Shoshani D; Schneidman M; Weizman A
    Clin Neuropharmacol; 1998; 21(2):97-100. PubMed ID: 9579295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.